Title 21, Part 524 — Ophthalmic and Topical Dosage Form New Animal Drugs
91 sections
Section 524.86
Amitraz.
Section 524.154
Bacitracin, neomycin, and polymyxin B ophthalmic ointment.
Section 524.155
Bacitracin, neomycin, polymyxin B, and hydrocortisone ophthalmic ointment.
Section 524.230
Buprenorphine.
Section 524.390
Chloramphenicol ophthalmic ointment.
Section 524.402
Chlorhexidine.
Section 524.450
Clotrimazole.
Section 524.463
Copper naphthenate.
Section 524.575
Cyclosporine ophthalmic ointment.
Section 524.590
Diclofenac.
Section 524.660
Dimethyl sulfoxide.
Section 524.770
Doramectin.
Section 524.775
Emodepside and praziquantel.
Section 524.802
Enrofloxacin and silver sulfadiazine otic emulsion.
Section 524.814
Eprinomectin.
Section 524.815
Eprinomectin and praziquantel.
Section 524.838
Esafoxolaner, eprinomectin, and praziquantel.
Section 524.900
Famphur.
Section 524.920
Fenthion.
Section 524.955
Florfenicol, terbinafine, and betamethasone acetate otic gel.
Section 524.957
Florfenicol, terbinafine, and mometasone otic solution.
Section 524.960
Flumethasone, neomycin, and polymyxin B ophthalmic solution.
Section 524.970
Flunixin.
Section 524.981
[Reserved]
Section 524.981a
Fluocinolone cream.
Section 524.981b
Fluocinolone solution.
Section 524.981c
Fluocinolone and neomycin cream.
Section 524.981d
Fluocinolone and dimethyl sulfoxide solution.
Section 524.981e
Fluocinolone and dimethyl sulfoxide otic solution.
Section 524.998
Fluralaner.
Section 524.1001
Fluralaner and moxidectin.
Section 524.1005
Furazolidone powder.
Section 524.1044
Gentamicin ophthalmic and topical dosage forms.
Section 524.1044a
Gentamicin ophthalmic solution.
Section 524.1044b
Gentamicin and betamethasone otic solution.
Section 524.1044c
Gentamicin ophthalmic ointment.
Section 524.1044d
Gentamicin and betamethasone ointment.
Section 524.1044e
Gentamicin spray.
Section 524.1044f
Gentamicin and betamethasone spray.
Section 524.1044g
Gentamicin, betamethasone, and clotrimazole ointment.
Section 524.1044h
Gentamicin, mometasone, and clotrimazole otic suspension.
Section 524.1044i
Gentamicin and betamethasone ophthalmic solution.
Section 524.1132
Hydrocortisone, miconazole, and gentamicin otic suspension.
Section 524.1140
Imidacloprid and ivermectin.
Section 524.1144j
Gentamicin, posaconazole, and mometasone furoate otic suspension.
Section 524.1146
Imidacloprid and moxidectin.
Section 524.1193
Ivermectin topical solution.
Section 524.1195
Ivermectin otic suspension.
Section 524.1200
Kanamycin ophthalmic and topical dosage forms.
Section 524.1200a
Kanamycin ophthalmic ointment.
Section 524.1200b
Kanamycin ophthalmic solution.
Section 524.1204
Kanamycin, amphomycin, and hydrocortisone ointment.
Section 524.1240
Levamisole.
Section 524.1312
Marbofloxacin, terbinafine, and dexamethasone otic suspension.
Section 524.1376
2-Mercaptobenzothiazole solution.
Section 524.1443
Miconazole.
Section 524.1445
Miconazole, polymixin B, and prednisolone suspension.
Section 524.1446
Milbemycin otic solution.
Section 524.1448
Mirtazapine transdermal ointment.
Section 524.1450
Moxidectin.
Section 524.1465
Mupirocin.
Section 524.1484
Neomycin ophthalmic and topical dosage forms.
Section 524.1484b
Neomycin, isoflupredone, and tetracaine powder.
Section 524.1484c
Neomycin, isoflupredone, and tetracaine ointment.
Section 524.1484d
Neomycin, hydrocortisone, and tetracaine otic ointment.
Section 524.1484e
Neomycin and polymyxin B ophthalmic solution.
Section 524.1484f
Neomycin, prednisolone, and tetracaine otic suspension.
Section 524.1484g
Neomycin, thiabendazole, and dexamethasone solution.
Section 524.1484h
Neomycin, penicillin, polymyxin B, and hydrocortisone suspension.
Section 524.1484i
Neomycin and hydrocortisone ointment.
Section 524.1484k
Neomycin and prednisolone suspension.
Section 524.1580
Nitrofurazone topical dosage forms.
Section 524.1580a
Nitrofurazone ointment.
Section 524.1580b
Nitrofurazone soluble powder.
Section 524.1600
Nystatin ophthalmic and topical dosage forms.
Section 524.1600a
Nystatin, neomycin, thiostrepton, and triamcinolone ointment.
Section 524.1600b
Nystatin, neomycin, thiostrepton, and triamcinolone ophthalmic ointment.
Section 524.1610
Orbifloxacin, mometasone furoate monohydrate, and posaconazole suspension.
Section 524.1662
Oxytetracycline ophthalmic and topical dosage forms.
Section 524.1662a
Oxytetracycline and hydrocortisone spray.
Section 524.1662b
Oxytetracycline and polymyxin B ophthalmic ointment.
Section 524.1742
Phosmet emulsifiable liquid.
Section 524.1982
Proparacaine ophthalmic solution.
Section 524.2080
Ropinirole.
Section 524.2098
Selamectin.
Section 524.2099
Selamectin and sarolaner.
Section 524.2101
Selenium disulfide suspension.
Section 524.2338
Terbinafine and betamethasone acetate.
Section 524.2350
Tolnaftate cream.
Section 524.2482
Triamcinolone spray.
Section 524.2620
Liquid crystalline trypsin, Peru balsam, castor oil.